Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Agatolimod (ODN 2006) is a TLR9 agonist, a class B ODN (oligodeoxynucleotide) and the optimal human CpG sequence (sequence: 5'-tcgtcgttttttgtcgttttgtcgtt-3'). agatolimod stimulates NO2 and IL-6 production in HD11 cells. Agatolimod can be used to study breast cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | Inquiry | |
50 mg | 10-14 weeks | Inquiry | |
100 mg | 10-14 weeks | Inquiry |
Description | Agatolimod (ODN 2006) is a TLR9 agonist, a class B ODN (oligodeoxynucleotide) and the optimal human CpG sequence (sequence: 5'-tcgtcgttttttgtcgttttgtcgtt-3'). agatolimod stimulates NO2 and IL-6 production in HD11 cells. Agatolimod can be used to study breast cancer. |
Molecular Weight | N/A |
CAS No. | 525625-52-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Agatolimod 525625-52-9 inhibitor inhibit